|
Israel Prize for researcher who developed drug to slow dementia
Jerusalem Post Marta Weinstock-Rosin, developer of a drug to slow dementia caused by Alzheimer's and Parkinson's disease, will receive the Israel Prize for Medicine on Independence Day. Weinstock-Rosin, of the HU School of Pharmacy-Institute for Drug Research in the … |
Month: March 2014
Prana Biotechnology Limited (ADR) (PRAN) news: Bipolar Prana: PBT2 For … – Seeking Alpha
|
Prana Biotechnology Limited (ADR) (PRAN) news: Bipolar Prana: PBT2 For …
Seeking Alpha The REACH2HD results were encouraging as the hurdles for PBT2's use in Huntington's disease will be much lower, but it is the Alzheimer's dementia indication where the big money lies. At a market capitalisation approaching $500m, PRAN no longer has … |